Hui Hui Li
Direktor/Vorstandsmitglied bei Ample Harvest Investments Ltd.
Profil
Hui Hui Li is currently a Director at Excel Partner Holdings Ltd., Ample Harvest Investments Ltd., and Vice President at Shenyang Sunshine Pharmaceuticals Co., Ltd.
In the past, Li was a Director at Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
and Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Li also served as Joint Secretary at 3SBio, Inc. from 2013 to 2016.
Li received an undergraduate degree and an MBA from Shanghai University of Finance & Economics in 2005.
Aktive Positionen von Hui Hui Li
Unternehmen | Position | Beginn |
---|---|---|
Ample Harvest Investments Ltd.
Ample Harvest Investments Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Ample Harvest Investments Ltd. provides investment services. | Direktor/Vorstandsmitglied | 01.12.2014 |
Excel Partner Holdings Ltd.
Excel Partner Holdings Ltd. MiscellaneousMiscellaneous Part of 3SBio, Inc., Excel Partner Holdings Ltd. operates as a holding Chinese company. The company is based in Hong Kong, Hong Kong. Excel Partner Holdings was acquired by 3SBio, Inc. from First Shanghai Investments Ltd. on December 31, 2014 for $25.25 million. | Direktor/Vorstandsmitglied | 01.12.2014 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Corporate Officer/Principal | 01.09.2013 |
Ehemalige bekannte Positionen von Hui Hui Li
Unternehmen | Position | Ende |
---|---|---|
3SBIO INC. | Unternehmenssekretär | 29.04.2016 |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Direktor/Vorstandsmitglied | - |
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Hui Hui Li
Shanghai University of Finance & Economics | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
3SBIO INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Ample Harvest Investments Ltd.
Ample Harvest Investments Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Ample Harvest Investments Ltd. provides investment services. | Finance |
Excel Partner Holdings Ltd.
Excel Partner Holdings Ltd. MiscellaneousMiscellaneous Part of 3SBio, Inc., Excel Partner Holdings Ltd. operates as a holding Chinese company. The company is based in Hong Kong, Hong Kong. Excel Partner Holdings was acquired by 3SBio, Inc. from First Shanghai Investments Ltd. on December 31, 2014 for $25.25 million. | Miscellaneous |
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China. | Health Technology |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Health Technology |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |